84 related articles for article (PubMed ID: 30548446)
1. Downregulation of tyrosine hydroxylase phenotype after AAV injection above substantia nigra: Caution in experimental models of Parkinson's disease.
Albert K; Voutilainen MH; Domanskyi A; Piepponen TP; Ahola S; Tuominen RK; Richie C; Harvey BK; Airavaara M
J Neurosci Res; 2019 Mar; 97(3):346-361. PubMed ID: 30548446
[TBL] [Abstract][Full Text] [Related]
2. T cell infiltration and upregulation of MHCII in microglia leads to accelerated neuronal loss in an α-synuclein rat model of Parkinson's disease.
Subbarayan MS; Hudson C; Moss LD; Nash KR; Bickford PC
J Neuroinflammation; 2020 Aug; 17(1):242. PubMed ID: 32799878
[TBL] [Abstract][Full Text] [Related]
3. Modeling Parkinson's disease pathology by combination of fibril seeds and α-synuclein overexpression in the rat brain.
Thakur P; Breger LS; Lundblad M; Wan OW; Mattsson B; Luk KC; Lee VMY; Trojanowski JQ; Björklund A
Proc Natl Acad Sci U S A; 2017 Sep; 114(39):E8284-E8293. PubMed ID: 28900002
[TBL] [Abstract][Full Text] [Related]
4. Ciita Regulates Local and Systemic Immune Responses in a Combined rAAV-α-synuclein and Preformed Fibril-Induced Rat Model for Parkinson's Disease.
Fredlund F; Jimenez-Ferrer I; Grabert K; Belfiori LF; Luk K; Swanberg M
J Parkinsons Dis; 2024; 14(4):693-711. PubMed ID: 38728204
[TBL] [Abstract][Full Text] [Related]
5. Reduction of alpha-synuclein oligomers in preclinical models of Parkinson's disease by electrical stimulation in vitro and deep brain stimulation in vivo.
Lee EJ; Aguirre-Padilla DH; Fomenko A; Pawar G; Kapadia M; George J; Lozano AM; Hamani C; Kalia LV; Kalia SK
Brain Stimul; 2024; 17(2):166-175. PubMed ID: 38342364
[TBL] [Abstract][Full Text] [Related]
6. α-Synuclein Expression Is Preserved in Substantia Nigra GABAergic Fibers of Young and Aged Neurotoxin-Treated Rhesus Monkeys.
Vermilyea SC; Guthrie S; Hernandez I; Bondarenko V; Emborg ME
Cell Transplant; 2019 Apr; 28(4):379-387. PubMed ID: 30857404
[TBL] [Abstract][Full Text] [Related]
7. Development of an Alpha-synuclein Based Rat Model for Parkinson's Disease via Stereotactic Injection of a Recombinant Adeno-associated Viral Vector.
Van der Perren A; Casteels C; Van Laere K; Gijsbers R; Van den Haute C; Baekelandt V
J Vis Exp; 2016 Feb; (108):53670. PubMed ID: 26967677
[TBL] [Abstract][Full Text] [Related]
8. Human α-synuclein overexpression upregulates SKOR1 in a rat model of simulated nigrostriatal ageing.
Morales-Prieto N; Bevans R; O'Mahony A; Barron A; Giles Doran C; McCarthy E; Concannon RM; Goulding SR; McCarthy CM; Collins LM; Sullivan AM; O'Keeffe GW
Aging Cell; 2024 Jun; 23(6):e14155. PubMed ID: 38529808
[TBL] [Abstract][Full Text] [Related]
9. Chronic nigral neuromodulation aggravates behavioral deficits and synaptic changes in an α-synuclein based rat model for Parkinson's disease.
Torre-Muruzabal T; Devoght J; Van den Haute C; Brône B; Van der Perren A; Baekelandt V
Acta Neuropathol Commun; 2019 Oct; 7(1):160. PubMed ID: 31640762
[TBL] [Abstract][Full Text] [Related]
10. [Improvement effect of cinnamaldehyde on reserpine-induced Parkinson's disease rat model].
Jiao PP; Dong BB; Wu SH; Yan HM; Li HB; Li GL
Zhongguo Zhong Yao Za Zhi; 2024 Mar; 49(5):1318-1326. PubMed ID: 38621979
[TBL] [Abstract][Full Text] [Related]
11. Synapsin III gene silencing redeems alpha-synuclein transgenic mice from Parkinson's disease-like phenotype.
Faustini G; Longhena F; Masato A; Bassareo V; Frau R; Klingstedt T; Shirani H; Brembati V; Parrella E; Vezzoli M; Nilsson KPR; Pizzi M; Spillantini MG; Bubacco L; Bellucci A
Mol Ther; 2022 Apr; 30(4):1465-1483. PubMed ID: 35038583
[TBL] [Abstract][Full Text] [Related]
12. Acrolein-mediated alpha-synuclein pathology involvement in the early post-injury pathogenesis of mild blast-induced Parkinsonian neurodegeneration.
Acosta G; Race N; Herr S; Fernandez J; Tang J; Rogers E; Shi R
Mol Cell Neurosci; 2019 Jul; 98():140-154. PubMed ID: 31201929
[TBL] [Abstract][Full Text] [Related]
13. Intranasal administration of α-synuclein preformed fibrils triggers microglial iron deposition in the substantia nigra of Macaca fascicularis.
Guo JJ; Yue F; Song DY; Bousset L; Liang X; Tang J; Yuan L; Li W; Melki R; Tang Y; Chan P; Guo C; Li JY
Cell Death Dis; 2021 Jan; 12(1):81. PubMed ID: 33441545
[TBL] [Abstract][Full Text] [Related]
14. Stress and corticosterone alter synaptic plasticity in a rat model of Parkinson's disease.
Hao Y; Shabanpoor A; Metz GA
Neurosci Lett; 2017 Jun; 651():79-87. PubMed ID: 28473257
[TBL] [Abstract][Full Text] [Related]
15. Exercise-Mediated Increase in Nigral Tyrosine Hydroxylase Is Accompanied by Increased Nigral GFR-α1 and EAAC1 Expression in Aging Rats.
Arnold JC; Salvatore MF
ACS Chem Neurosci; 2016 Feb; 7(2):227-39. PubMed ID: 26599339
[TBL] [Abstract][Full Text] [Related]
16. MicroRNA-124-3p Modulates Alpha-Synuclein Expression Levels in a Paraquat-Induced in vivo Model for Parkinson's Disease.
Esteves M; Cristóvão AC; Vale A; Machado-Pereira M; Ferreira R; Bernardino L
Neurochem Res; 2024 Jul; 49(7):1677-1686. PubMed ID: 38451434
[TBL] [Abstract][Full Text] [Related]
17. Sequential or Simultaneous Injection of Preformed Fibrils and AAV Overexpression of Alpha-Synuclein Are Equipotent in Producing Relevant Pathology and Behavioral Deficits.
Negrini M; Tomasello G; Davidsson M; Fenyi A; Adant C; Hauser S; Espa E; Gubinelli F; Manfredsson FP; Melki R; Heuer A
J Parkinsons Dis; 2022; 12(4):1133-1153. PubMed ID: 35213388
[TBL] [Abstract][Full Text] [Related]
18. Substantia nigra vulnerability after a single moderate diffuse brain injury in the rat.
van Bregt DR; Thomas TC; Hinzman JM; Cao T; Liu M; Bing G; Gerhardt GA; Pauly JR; Lifshitz J
Exp Neurol; 2012 Mar; 234(1):8-19. PubMed ID: 22178300
[TBL] [Abstract][Full Text] [Related]
19. The role of alpha-synuclein in melanin synthesis in melanoma and dopaminergic neuronal cells.
Pan T; Zhu J; Hwu WJ; Jankovic J
PLoS One; 2012; 7(9):e45183. PubMed ID: 23028833
[TBL] [Abstract][Full Text] [Related]
20. Neuromelanin in Parkinson's Disease: Tyrosine Hydroxylase and Tyrosinase.
Nagatsu T; Nakashima A; Watanabe H; Ito S; Wakamatsu K
Int J Mol Sci; 2022 Apr; 23(8):. PubMed ID: 35456994
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]